New research reveals organized networks linking paper mills, intermediaries, and compromised academic journals
Organized scientific fraud is becoming increasingly common, ranging from fabricated research to the buying and selling of authorship and citations, according to a new study from Northwestern University.
The researchers conducted an in-depth examination of scientific misconduct by pairing large-scale analyses of published research with detailed case studies. While discussions of research fraud often center on individual wrongdoing, the Northwestern team identified complex international networks made up of people and organizations that deliberately coordinate efforts to compromise the academic publishing system.
The problem is so widespread that the publication of fraudulent science is outpacing the growth rate of legitimate scientific publications. The authors say this trend should alert the scientific community to the urgency of the situation and prompt action before public trust in science is seriously damaged.
The study was published in the journal Proceedings of the National Academy of Sciences.
"Science must police itself better in order to preserve its integrity," said Northwestern's Luís A. N. Amaral, the study's senior author. "If we do not create awareness around this problem, worse and worse behavior will become normalized. At some point, it will be too late, and scientific literature will become completely poisoned. Some people worry that talking about this issue is attacking science. But I strongly believe we are defending science from bad actors. We need to be aware of the seriousness of this problem and take measures to address it."
Amaral is an expert in complex social systems and serves as the Erastus Otis Haven Professor, as well as a professor of engineering sciences and applied mathematics, at Northwestern's McCormick School of Engineering. Reese Richardson, a postdoctoral fellow in Amaral's laboratory, is the study's first author.
Extensive analysis
When people think about scientific fraud, they might remember news reports of retracted papers, falsified data or plagiarism. These reports typically center around the isolated actions of one individual, who takes shortcuts to get ahead in an increasingly competitive industry. But Amaral and his team uncovered a widespread underground network operating within the shadows and outside of the public's awareness.
"These networks are essentially criminal organizations, acting together to fake the process of science," Amaral said. "Millions of dollars are involved in these processes."
To conduct the study, the researchers analyzed extensive datasets of retracted publications, editorial records and instances of image duplication. Most of the data came from major aggregators of scientific literature, including Web of Science (WoS), Elsevier's Scopus, National Library of Medicine's PubMed/MEDLINE and OpenAlex, which includes data from Microsoft Academic Graph, Crossref, ORCID, Unpaywall and other institutional repositories.
Richardson and his colleagues also collected lists of de-indexed journals, which are scholarly journals that have been removed from databases for failing to meet certain quality or ethical standards. The researchers also included data on retracted articles from Retraction Watch, article comments from PubPeer and metadata — such as editor names, submission dates, and acceptance dates — from articles published in specific journals.
Buying a reputation
After analyzing the data, the team uncovered coordinated efforts involving "paper mills," brokers, and infiltrated journals. Functioning much like factories, paper mills churn out large numbers of manuscripts, which they then sell to academics who want to quickly publish new work. These manuscripts are mostly low quality — featuring fabricated data, manipulated or even stolen images, plagiarized content, and sometimes nonsensical or physically impossible claims.
"More and more scientists are being caught up in paper mills," Amaral said. "Not only can they buy papers, but they can buy citations. Then, they can appear like well-reputed scientists when they have barely conducted their own research at all."
"Paper mills operate by a variety of different models," Richardson added. "So, we have only just been able to scratch the surface of how they operate. But they sell basically anything that can be used to launder a reputation. They often sell authorship slots for hundreds or even thousands of dollars. A person might pay more money for the first author position or less money for a fourth author position. People also can pay to get papers they have written automatically accepted in a journal through a sham peer-review process."
To identify more articles originating from paper mills, the Amaral group launched a parallel project that automatically scans published materials science and engineering papers. The team specifically looked for authors who misidentified instruments they used in their research. A paper with those results was accepted by the journal PLOS ONE.
Brokers, hijacking, and collusion
Amaral, Richardson and their collaborators found fraudulent networks use several key strategies: (1) Groups of researchers collude to publish papers across multiple journals. When their activities are discovered, the papers are subsequently retracted; (2) brokers serve as intermediaries to enable mass publication of fraudulent papers in compromised journals; (3) fraudulent activities are concentrated in specific, vulnerable subfields; and (4) organized entities evade quality-control measures, such as journal de-indexing.
"Brokers connect all the different people behind the scenes," Amaral said. "You need to find someone to write the paper. You need to find people willing to pay to be the authors. You need to find a journal where you can get it all published. And you need editors in that journal who will accept that paper."
Sometimes these organizations go around established journals altogether, searching instead for defunct journals to hijack. When a legitimate journal stops publishing, for example, bad actors can take over its name or website. These actors surreptitiously assume the journal's identity, lending credibility to its fraudulent publications, despite the actual publication being defunct.
"This happened to the journal HIV Nursing," Richardson said. "It was formerly the journal of a professional nursing organization in the U.K., then it stopped publishing, and its online domain lapsed. An organization bought the domain name and started publishing thousands of papers on subjects completely unrelated to nursing, all indexed in Scopus."
Fighting for science
To combat this growing threat to legitimate scientific publishing, Amaral and Richardson emphasize the need for a multi-prong approach. This approach includes enhanced scrutiny of editorial processes, improved methods for detecting fabricated research, a greater understanding of the networks facilitating this misconduct and a radical restructuring of the system of incentives in science.
Amaral and Richardson also underscore the importance of addressing these issues before artificial intelligence (AI) infiltrates scientific literature more than it already has.
"If we're not prepared to deal with the fraud that's already occurring, then we're certainly not prepared to deal with what generative AI can do to scientific literature," Richardson said. "We have no clue what's going to end up in the literature, what's going to be regarded as scientific fact, and what's going to be used to train future AI models, which then will be used to write more papers."
"This study is probably the most depressing project I've been involved with in my entire life," Amaral said. "Since I was a kid, I was excited about science. It's distressing to see others engage in fraud and in misleading others. But if you believe that science is useful and important for humanity, then you have to fight for it."
Reference: "The entities enabling scientific fraud at scale are large, resilient, and growing rapidly" by Reese A. K. Richardson, Spencer S. Hong, Jennifer A. Byrne, Thomas Stoeger and Luís A. Nunes Amaral, 4 August 2025, Proceedings of the National Academy of Sciences.
DOI: 10.1073/pnas.2420092122
The study was supported by the National Science Foundation and the National Institutes of Health.
News
Cancer’s Hidden Antioxidant Shield Helps It Escape the Immune System
Blocking an antioxidant protein that tumors use to suppress immune attacks improved cancer immunotherapy responses in mice. Cancer cells can release antioxidants that interfere with the immune cells trying to kill them. Researchers have [...]
Scientists Find a Berry Compound That Helps Muscle Cells Burn Fat
Pterostilbene, a compound found naturally in some foods, affects how skeletal muscles process fats by stabilizing a protein called PPARδ and increasing its signaling activity. Pterostilbene, a natural compound found in blueberries, grapes, and [...]
Two Hidden Forces Help Build the Human Brain Before Birth
Scientists have uncovered two surprising forces that help guide how the human brain forms before birth. Before birth, the human brain is shaped in large part by an unusual class of stem cells known [...]
Researchers Uncover a Hidden Trigger Behind Chronic Inflammation
The findings offer new insights that could help guide the development of future therapies. A protein called human resistin may help flip on one of the immune system’s most powerful inflammatory switches. Researchers at [...]
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]















